ArticleTargeted oncology2026

A Podcast on Osimertinib After CRT in Unresectable Stage III EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): Current and Future Perspectives.

Thanyanan Reungwetwattana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.